Avantor, Inc. (NYSE:AVTR) Shares Sold by Mount Yale Investment Advisors LLC

Mount Yale Investment Advisors LLC cut its position in Avantor, Inc. (NYSE:AVTR) by 29.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,250 shares of the company’s stock after selling 5,472 shares during the period. Mount Yale Investment Advisors LLC’s holdings in Avantor were worth $281,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Jennison Associates LLC boosted its stake in Avantor by 113.0% during the 1st quarter. Jennison Associates LLC now owns 2,497,349 shares of the company’s stock worth $63,857,000 after purchasing an additional 1,325,026 shares during the last quarter. Swedbank AB acquired a new position in Avantor during the first quarter worth about $2,707,000. Diversify Advisory Services LLC purchased a new stake in Avantor during the 1st quarter valued at about $908,000. CenterBook Partners LP acquired a new stake in Avantor in the 4th quarter valued at about $4,562,000. Finally, APG Asset Management US Inc. purchased a new position in Avantor in the 4th quarter worth approximately $2,971,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AVTR has been the topic of a number of analyst reports. Stifel Nicolaus lifted their price objective on Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. TD Cowen boosted their price target on shares of Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Morgan Stanley upped their price objective on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a report on Monday, July 29th. Evercore ISI reduced their target price on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. Finally, Wells Fargo & Company began coverage on shares of Avantor in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $30.00 price target for the company. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $27.40.

Insider Buying and Selling at Avantor

In other news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now directly owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.50% of the company’s stock.

Avantor Price Performance

Shares of NYSE AVTR opened at $26.56 on Wednesday. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. The company has a market cap of $18.04 billion, a price-to-earnings ratio of 68.10, a price-to-earnings-growth ratio of 2.75 and a beta of 1.32. The stock’s 50-day moving average is $25.26 and its two-hundred day moving average is $24.36. Avantor, Inc. has a 1-year low of $16.63 and a 1-year high of $28.00.

Avantor (NYSE:AVTR) last released its earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.02. The firm had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.70 billion. Avantor had a net margin of 5.28% and a return on equity of 12.40%. Analysts forecast that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.